Relapses in rituximab (RIT)-treated Wegener's granulomatosis (WG) patients despite peripheral B-cell depletion

被引：0
|
作者：
Molloy, Eamonn [1 ]
Koening, Curry [2 ]
Hernandez-Rodriguez, Jose [3 ]
Clark, Tiffany [1 ]
Langford, Carol [1 ]
Hoffman, Gary [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Utah, Div Rheumatol, Salt Lake City, UT USA
[3] Univ Barcelona, Hosp Clin, Barcelona, Spain
来源：
APMIS | 2009年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [21] Rituximab toxicity in patients with peripheral blood malignant B-cell lymphocytosis
    Kanelli, S
    Ansell, SM
    Habermann, TM
    Inwards, DJ
    Tuinstra, N
    Witzig, TE
    LEUKEMIA & LYMPHOMA, 2001, 42 (06) : 1329 - 1337
  • [22] Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
    Wang, Yucai
    Farooq, Umar
    Link, Brian K.
    Larson, Melissa C.
    King, Rebecca L.
    Maurer, Matthew J.
    Allmer, Cristine
    Hefazi, Mehrdad
    Thompson, Carrie A.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Ansell, Stephen M.
    Cerhan, James R.
    Nowakowski, Grzegorz S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (21) : 1819 - +
  • [23] Treatment of RA with rituximab leads to selected peripheral B-cell depletion with minimal effect on immunoglobulins
    Szechinski, J
    Szczepanski, L
    Filipowicz-Sosnowska, A
    Stahj, HD
    Edwards, JCW
    Close, DR
    Stevens, R
    Shaw, TW
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 171 - 171
  • [24] Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?
    Reddy, Venkat R.
    Pepper, Ruth J.
    Shah, Kavina
    Cambridge, Geraldine
    Henderson, Scott R.
    Klein, Christian
    Kell, Loren
    Taylor, Samuel J.
    Isenberg, David A.
    Cragg, Mark S.
    Leandro, Maria J.
    RHEUMATOLOGY, 2022, 61 (07) : 2894 - 2904
  • [25] PHENOTYPIC CHANGES OF LYMPHOCYTES IN PATIENTS WITH SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH AN INTENSIFIED B-CELL DEPLETION THERAPY WITH RITUXIMAB
    Sciascia, S.
    Baldovino, S.
    Menegatti, E.
    Solfietti, L.
    Di Simone, D.
    Rossi, D.
    Roccatello, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 560 - 560
  • [26] RELATION OF SUBCLINICAL ULTRASOUND DETECTED SYNOVITIS AND PERIPHERAL B-CELL COUNTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH RITUXIMAB
    Estupinan, L. P. Martinez
    Naredo, E.
    Valor, L.
    Janta, I.
    Montoro, M.
    Del Rio, T.
    Nieto-Gonzalez, J. C.
    Hinojosa, M.
    Bello, N.
    Martinez, J.
    Gonzalez-Fernandez, C.
    Lopez-Longo, J.
    Monteagudo, I.
    Carreno-Perez, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 951 - 951
  • [27] B-Cell Depletion With Rituximab in Patients With Primary Biliary Cirrhosis Refractory to Ursodeoxycholic Acid
    Myers, Robert P.
    Swain, Mark G.
    Lee, Samuel S.
    Shaheen, Abdel Aziz M.
    Burak, Kelly W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (06): : 933 - 941
  • [28] Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases
    Memon, Anza B.
    Javed, Adil
    Caon, Christina
    Srivastawa, Shitiz
    Bao, Fen
    Bernitsas, Evanthia
    Chorostecki, Jessica
    Tselis, Alexandros
    Seraji-Bozorgzad, Navid
    Khan, Omar
    PLOS ONE, 2018, 13 (01):
  • [29] Discrepancy in Rituximab-Induced B-Cell Depletion in Peripheral Blood and the Kidney and Relationship with Clinical Response in Patients with Lupus Nephritis
    Pepper, Ruth J.
    Reddy, Venkat
    Henderson, Scott
    Leandro, Maria J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [30] Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy)
    Waite, L.
    Morrison, E.
    LUPUS, 2007, 16 (10) : 841 - 842
12345